SEC Form 4/A · accession 0001104659-18-072160
Equitrans Midstream Corp · ETRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
David L Porges
Director
Period of report
Nov 12, 2018
Accepted (ET)
Dec 10, 2018 · 6:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001747009
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1,F2 | $33.96 | Nov 12, 2018 | A | 83,761 | A | — | Jan 1, 2022 | Common Stock | 83,761 | 83,761 | D |
| Employee Stock Option (Right to Buy)F1,F2 | $36.55 | Nov 12, 2018 | A | 73,153 | A | — | Jan 1, 2023 | Common Stock | 73,153 | 73,153 | D |
| Employee Stock Option (Right to Buy)F1,F2 | $55.64 | Nov 12, 2018 | A | 37,684 | A | — | Jan 1, 2024 | Common Stock | 37,684 | 37,684 | D |
| Employee Stock Option (Right to Buy)F1,F2 | $46.92 | Nov 12, 2018 | A | 42,672 | A | — | Jan 1, 2025 | Common Stock | 42,672 | 42,672 | D |
| Employee Stock Option (Right to Buy)F1 | $32.31 | Nov 12, 2018 | A | 61,910 | A | Jan 1, 2019 | Jan 1, 2026 | Common Stock | 61,910 | 61,910 | D |
Explanation of responses
- F1In connection with the spin-off of Equitrans Midstream Corporation (ETRN) from EQT Corporation (EQT) on November 12, 2018, for each outstanding EQT stock option award held by the Reporting Person immediately prior to the spin-off, the Reporting Person received a stock option award from ETRN. The number of underlying shares and exercise price of each ETRN stock option award were calculated in a manner intended to preserve the aggregate intrinsic value of the original EQT stock option award (based in part on the volume weighted average per-share price of ETRN's common stock during each of the first ten full NYSE trading sessions commencing November 13, 2018). This amendment is being filed to correct the previously disclosed exercise price calculated in respect of each grant.
- F2The option has vested as to all shares subject to the grant.